Clinical trial
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
NCT01724112 is registered in ClinicalTrials.gov with BlackThorn Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
- Lead sponsor
- BlackThorn Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- March 31, 2014
- Enrollment
- 136 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.